Rafferty Asset Management, LLC
Position in RCKT — Rocket Pharmaceuticals, Inc.
CIK 1389426
New York, NY
Position in RCKT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$505,538
-$534,148 QoQ
Shares Held
141,212
-9.4% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCKT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $408,627,656 across 136 Biotechnology names. RCKT ranks #125 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,572 | $24,368,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,589 | $22,861,644 | |
| 3 | INSM |
INSMED Inc
|
116,069 | $18,979,602 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
50,553 | $16,726,471 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
180,471 | $7,260,348 | |
| 6 | MRNA |
Moderna, Inc.
|
114,194 | $5,801,055 | |
| 7 | INCY |
Incyte Corp
|
60,565 | $5,700,377 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,452 | $5,471,308 |
All Filings in RCKT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $505,538 | 141,212 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $1,039,686 | 155,875 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,964,188 | 156,260 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,377,569 | 128,726 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,532,896 | 117,645 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,864,418 | 329,043 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $6,248,894 | 208,505 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,951,244 | 241,642 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,631,379 | 233,084 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,129,732 | 299,459 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,752,816 | 293,961 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,615,227 | 226,518 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,191,918 | 86,622 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,621,229 | 165,273 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,152,404 | 144,407 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,636,118 | 88,194 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,501,809 | 56,487 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,756,841 | 62,133 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $382,234 | 6,970 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $841,750 | 36,822 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $310,747 | 14,847 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||